Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units

Medell, Manuel; Medell, Mariana; Martínez, Alicia; Valdés, Rodolfo

doi:10.1016/S1413-8670(12)70273-8

Article information

Abstract

Objectiv

Thisobservational study described the characterization of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units. The demonstration of isolated microorganism resistance to antibiotics and a time-trend analysis of infection comparing a 48-month period were also other objectives.

Method

Semi-quantitative assays of 1254 samples taken from 741 ventilated patients were performed, while pathogens were identified using the Enterotube II assay and VITEK 2 Compact equipment. Bacterial resistance to antibiotics was assessed by the Kirby-Bauer disc diffusion method and time-trend analysis of infection was based on data recorded by hospital microbiology laboratories.

Results

The most prevalent isolated bacteria from the patient's lower respiratory tract were with Gram-negative bacteria (67.8%) mostly represented by: Acinetobacter spp. (25.2%), Pseudomonas spp. (18.3%) and Klebsiellas spp. (9.4%). Acinetobacter spp. showed moderate high to very high resistance to ceftriaxone (CRO), gentamicin (CN), amikacin (AK), meropenem (MRP), aztreonam (ATM) and piperacillin/tazobactam (TZP). Some isolates of Acinetobacter spp. resistant to colistin (CS) were identified in this patient population. Pseudomonas spp. and Klebsiella spp. were very highly resistant to ampicillin/sublactam (AMS) and with moderate or low resistance to CRO, ATM, MRP, AK, CN and TZP. A decrease in the Pseudomonas spp. prevalence rate was observed, whereas an increase in Acinetobacter spp. and Klebsiella spp. prevalence rates were observed in a 48-month period.

Conclusion

This research corroborated that these nosocomial infections are a relevant medical problem in our context. The most prevalent bacterial infections in the lower respiratory tract of ventilated patients were by Acinetobacter spp., Pseudomonas spp. and Klebsiella spp. The panel of antibiotics used as preventive therapy was not the solution of infections and probably induced drug-resistance mechanisms in these isolated microorganisms.

Keywords:

Anti-bacterial agents

Respiratory care units

Bronchopneumonia

Full text is only aviable in PDF

References

[1.]

G. Majno.

The ancient riddle of σñψις (sepsis).

J Infect Dis, 163 (1991), pp. 937-945

Medline

[2.]

S. Slaughter, M.K. Hayden, C. Nathan, et al.

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant Enterococci in a medical intensive care unit.

Ann Intern Med, 125 (1996), pp. 448-456

Medline

[3.]

C.S. Boye, A.I. Sow.

Nosocomial infections: main causative agents. Reported as causal agents of nosocomial infections.

Dakar Med, 52 (2007), pp. 77-81

Medline

[4.]

R.W. Haley, D.H. Culver, J.W. White, et al.

The nationwide nosocomial infection rate: a new need for vital statistics.

Am J Epidemiol, 121 (1985), pp. 159-167

Medline

[5.]

H.W. Boucher, G.H. Talbot, J.S. Bradley, et al.

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Clin Infect Dis, 48 (2009), pp. 1-12

http://dx.doi.org/10.1086/595011 | Medline

[6.]

R.A. Weinstein.

Epidemiology and control of nosocomial infections in adult intensive care units.

Am J Med, 91 (1991), pp. 179-184

Medline

[7.]

K. Hiramatsu, N. Aritaka, H. Hanaki, et al.

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Lancet, 350 (1997), pp. 1670-1673

http://dx.doi.org/10.1016/S0140-6736(97)07324-8 | Medline

[8.]

P.W. Stone, E.C. Hedblom, D.M. Murphy, et al.

The economic impact of infection control: making the business case for increased infection control resources.

Am J Infect Control, 33 (2005), pp. 542-547

http://dx.doi.org/10.1016/j.ajic.2005.08.003 | Medline

[9.]

National Committee for Clinical Laboratory Standards. Performance standards for antimicrobic disc susceptibility test. Approved standard M2-A2S2. 1981. National Committee for Clinical Laboratory Standards. Wayne Pa. EEUU.

[10.]

Y.P. Anton, C.H. David.

Hospital-acquired infections due to Gram-negative bacteria.

N Engl J Med, 362 (2010), pp. 1804-1813

http://dx.doi.org/10.1056/NEJMra0904124 | Medline

[11.]

R.G. Wunderink.

Attributable mortality of ventilator-associated pneumonia.

Sepsis, 1 (1998), pp. 211-221

[12.]

J.M. Tadié, L. Trinquart, C. Jannière-Nartey, et al.

Prediction of nosocomial infection acquisition in ventilated patients by nasal nitric oxide: Proof-of-Concept Study.

Shock, 34 (2010), pp. 217-221

http://dx.doi.org/10.1097/SHK.0b013e3181d67494 | Medline

[13.]

I. Chopra, C. Schofield, M. Everett, et al.

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.

Lancet Infect Dis, 8 (2008), pp. 133-139

http://dx.doi.org/10.1016/S1473-3099(08)70018-5 | Medline

[14.]

R.M. Klevens, J.R. Edwards, C.L. Richards, et al.

Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Public Health Rep, 122 (2007), pp. 160-166

Medline

[15.]

T.L. Daniels, S. Deppen, P.G. Arbogast, et al.

Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.

Infect Control Hosp Epidemiol, 11 (2008), pp. 1080-1083

[16.]

M.L. Haverkorn, M.F. Michel.

Nosocomial klebsiellas. I. Colonization of hospitalized patients.

J Hyg, 82 (1979), pp. 177-193

Medline

[17.]

A. Malini, E.K. Deepa, B.N. Gokul, et al.

Non-fermenting gram-negative bacilli infections in a tertiary care hospital in Kolar, Karnataka.

J Lab Physicians, 1 (2009), pp. 62-66

http://dx.doi.org/10.4103/0974-2727.59701 | Medline

[18.]

A. Diomedi.

Infecciones por Acinetobacter baumannii pan-resistente. Consideraciones epidemiológicas y de manejo antimicrobiano actualizado.

Rev Chil Infect, 22 (2008), pp. 298-320

[19.]

F. Espinosa, M. Hart, M.C. Halley, et al.

Bacterial resistance of isolated strains at “Hermanos Ameijeiras” Hospital.

Rev Cubana Med, 47 (2008), pp. 1-8

[20.]

M.E. Falagas, A.P. Grammatikos, A. Michalopoulos.

Potential of old-generation antibiotics to address current need for new antibiotics.

Expert Rev Anti Infect Ther, 6 (2008), pp. 593-600

http://dx.doi.org/10.1586/14787210.6.5.593 | Medline

[21.]

K.K. Kumarasamy, A. Mark, M.A. Toleman, et al.

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Lancet Infect Dis, 10 (2010), pp. 597-602

http://dx.doi.org/10.1016/S1473-3099(10)70143-2 | Medline

[22.]

A.O. Reis, D. Luz, M. Tognim, et al.

Polymyxin resistant Acinetobacter spp. isolates: what is next?.

Emerg Infect Dis, 9 (2003), pp. 50-51

[23.]

Y.K. Park, K.R. Peck, H.S. Cheong, et al.

Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea.

Emerg Infect Dis, 15 (2009), pp. 107-109

http://dx.doi.org/10.3201/eid1501.080758 | Medline

[24.]

M.D. Adams, G.C. Nickel, S. Bajaksouzian, et al.

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.

Antimicrob Agents Chemother, 53 (2009), pp. 3628-3634

http://dx.doi.org/10.1128/AAC.00284-09 | Medline

[25.]

S.J. Seligman.

Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram- negative bacteria.

Antimicrob Ag Chemother, 13 (1978), pp. 70-73

[26.]

L. Rong-Dih, H. Po-Ren, C.H. Shan-Chwen, et al.

Bacteremia due to Klebsiella oxytoca: clinical features of patients and antimicrobial susceptibilities of the isolates.

Clin Infect Dis, 24 (1997), pp. 1217-1222

Medline

[27.]

J.M. Tomas, V.J. Benedi, B. Ciurana, et al.

Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.

Infect Immun, 54 (1986), pp. 85-89

Medline

[28.]

R. Podschun, U. Ullmann.

Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Clin Microbiol Rev, 11 (1998), pp. 589-603

Medline

[29.]

Y. Yang, B.A. Rasmussen, D.M. Shlaes, Class A.

beta-lactamases-enzyme-inhibitor interactions and resistance.

Pharmacol Ther, 83 (1999), pp. 141-151

Medline

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter